Creating a Better World
with Digital Therapeutics
Hippo T&C is a healthcare company developing digital therapeutic devices using VR and AI technologies. We strive to solve mental health issues such as depression and ADHD scientifically and effectively.
Vision
Growing Together with Digital Therapeutics
We dream of a world where everyone is free from mental health issues and can live a better life with the help of technology.
Mission
Evidence-Based Innovative Digital Treatment
We develop clinically validated digital therapeutic devices and provide mental health solutions that are accessible to everyone.
Core Values
Scientific Approach
All solutions are developed based on clinical research and scientific evidence.
Patient-Centered
We prioritize patient treatment experience and quality of life improvement.
Pursuing Innovation
We present new treatment paradigms using cutting-edge technologies like VR and AI.
Trust and Safety
We build trust through strict quality control and personal data protection.
History
Explore the milestones of Hippo T&C.
Establishes U.S. Subsidiary (Hippo T&C USA, LLC)
6310 Hillside Court, Suite 160, Columbia, Maryland 21046 USA
BlueKare Designated as Innovative Medical Device
MFDS (Ministry of Food and Drug Safety) General No. 122
2025 Korea AI Innovation Award
Grand Prize in AI Healthcare Category
BlueKare Approved as Korea's First Digital Therapeutics for Depression
Ministry of Food and Drug Safety, License No. D제허25-1호
Issuance of Manufacturing License for Digital Medical Devices
Ministry of Food and Drug Safety, PUPH-T5MN-NKXW-M0RL
Certificate of Good Manufacturing Practice (GMP) for Medical Device Manufacturing and Quality Management
Graduated from the SKKU Business Incubation Center and Relocated Headquarters to Pangyo
502, A-dong, Pangyo Digital Center, 242, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
AttnKare-D, clinical trial termination at Mount Sinai Hospital in New York, USA
Jeffrey Newcorn Professor Research Team
Official Launch of Digital Health Solutions CogMo and WithBuddy
Selected as a 2024 Global ICT Future Unicorn
hosted by the Ministry of Science and ICT
Selected for the AI-based digital transformation project for public healthcare institutions
hosted by NIPA
Selected for Post TIPS hosted by the Ministry of SMEs and Startups
Initiation of investigator-initiated clinical trials for AttnKare-D at Mount Sinai Hospital in the United States
Poster presentation and booth exhibition of AttnKare-D and AttnKare-T at APSARD 2024
AttnKare-D, approved for confirmatory clinical trial by Ministry of Food and Drug Safety
AttnKare-D, clinical trial termination at the University of Nebraska Medical Center (UNMC), USA
AttnKare-D Research AACAP2023 Poster Exhibition
ADHD Symptom Assessment Using Artificial Intelligence to Parse Virtual Reality Task Performance
AttnKare-T, researcher clinical trial begins
Sungkyunkwan University School of Medicine, Korea Brain Research Institute
BlueKare-T, public medical project researcher clinical trial begins
Participation in public medical projects
AttnKare-D researcher clinical trial begins at the University of Nebraska, USA
BlueKare-T approved for confirmatory clinical trial by Ministry of Food and Drug Safety
Clinical trials at three institutions: Seoul Samsung Hospital, Seoul Asan Medical Center, and Seoul National University Bundang Hospital
Received order for NIPA global market entry project
BlueKare-T, SW Validation
KTL SW Validation & Cyber Security & Performance Evaluation, judged 'suitable' in 3 categories
AttnKare-D, SW Validation
KTL SW Validation & Cyber Security judged 'suitable' in 2 categories
Hippo T&C affiliated research institute selected as a specialized military service exception company
Hippo T&C Showcase held
AttnKare-D, AttnKare-D, BlueKare-T CES exhibition
AttnKare-D, approved for exploratory clinical trial by Ministry of Food and Drug Safety
Clinical trials at two institutions, Seoul Samsung Hospital and Changwon Samsung Hospital
AttnKare-D poster presentation and exhibition participation at APSARD
Received a commendation from the Minister of Science and ICT
Received a commendation from Gyeonggi Province Governor
Contribute to local economic development by revitalizing entrepreneurship
Selected for TIPS follow-up startup commercialization and overseas marketing project hosted by the Ministry of SMEs and Startups
Recognized as a K-GMP software (Software as a Medical Device) item
Received a commendation from Dong-A Ilbo President
AttnKare-D, acquired medical device SW validation
BlueKare-T, emotional disorder treatment software medical device grade 2 designated by the Ministry of Food and Drug Safety
AttnKare-D, cognitive assessment software medical device grade 2 designated by the Ministry of Food and Drug Safety
CES 2022 Innovation Award in Virtual-Augmented Reality/Digital Health-Wellness Category
Hippo T&C products displayed at CES 2022
AttnKare-D, AttnKare-T, BlueKare-T
Attracting pre-series investment
AttnKare experience center opened in Woongjin Playcity, Bucheon
Received order to develop digital treatment for depression in the Corona Blue Era
Hosted by the Ministry of Trade, Industry and Energy
Selected for TIPS (Tech Incubator Program for Startups) by the Ministry of SMEs and Startups
ADHD diagnosis and treatment development project
Acquisition of U-Tech Valley Certification of Kibo(KOREA TECHNOLOGY FINANCE CORPORATION)
Acquisition of Venture Business Certification
Establishment of Research Institute
Founding of Hippo T&C, Inc.
Message from the CEO
Tai-Myoung Chung
CEO / Founder
Hippo T&C was founded on the belief that "Hippocratic spirit can be realized through technology to care for people." Witnessing those suffering from mental health challenges firsthand, I became convinced that technology can serve as a true instrument of healing.
Digital therapeutics represent a new treatment paradigm — accessible to everyone, free from the side effects of medication. We are developing clinically validated solutions for ADHD, depression, and other mental health conditions, making a real difference in each patient's daily life.
Hippo T&C will continue to open up the future of digital healthcare through the convergence of technology and medicine. We appreciate your warm support and interest.
Career Highlights
- Professor & Dean, College of Software, Sungkyunkwan University
- President, Korean Society of Medical Informatics & Korea Information Processing Society
- ICT Advisor, Republic of Rwanda
- Vice-Chair, OECD Privacy Protection Division
- Member, Presidential Advisory Committee on e-Government
- Recipient, Order of Service Merit (Hong-jo), Republic of Korea
- Researcher, BBN Labs., USA
- Ph.D. in Computer Science, Purdue University, USA